Short answer
ASP Isotopes Inc. (ASPI) filed its Q1 2026 10-Q quarterly report on May 20, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $4M (up 279.4% year over year) with net income of −$7M.
Q1 2026 key financials · XBRL
- Revenue
- $4M
- +279.4% YoY
- Net income
- −$7M
- +15.8% YoY
- Operating margin
- -595.4%
- Gross margin
- 39.9%
- EPS (diluted)
- −$0.06
- +50.0% YoY
Source: XBRL data from the ASP Isotopes Inc. (ASPI) Q1 2026 10-Q on SEC EDGAR. USD.
ASP Isotopes Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided; supplied text covers Items 2–6 and signatures only
- New financing documents: three addenda to the Renergen term loan facility dated January 15, February 26, and April 16, 2026
- New equity financing: Series Seed-1 Preferred Stock Purchase Agreement with Opeongo dated January 26, 2026
- Repeated debt waivers: six Tetra4 finance-agreement consents or waivers dated January 2024 through November 2025
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ASP Isotopes Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.